Corona Vaccins First Dose Efficacy: Difference between revisions
From Tech
Jump to navigationJump to search
Content deleted Content added
No edit summary |
|||
| Line 5: | Line 5: | ||
=Moderna= |
=Moderna= |
||
[https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
[https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
||
[[File: |
[[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|frame|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set] |
||
Revision as of 09:47, 11 July 2021
Pfizer
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Moderna
Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020 [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|frame|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set]